Showing results (1-10 of 618) with videos related to
Sort By:
Pageof 62
Praxis|November 17, 2011
[Topical therapy of ulcerative colitis]G Rogler, C Beglinger, C Mottet, et al.Journal of Crohn'S & Colitis|April 10, 2013
Topical therapy is underused in patients with ulcerative colitisF Seibold, N Fournier, C Beglinger, et al.Alimentary Pharmacology & Therapeutics|October 13, 2010
Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohortV Pittet, P Juillerat, P Michetti, et al.Alimentary Pharmacology & Therapeutics|July 8, 2015
Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patientsE Safroneeva, S Vavricka, N Fournier, et al.Clinical Pharmacology and Therapeutics|May 1, 1999
Dose-dependent gastrointestinal effects of the somatostatin analog lanreotide in healthy volunteersJ Drewe, C C Sieber, C Mottet, et al.Scandinavian Journal of Gastroenterology|May 11, 2001
Role of gender upon basal and postprandial systemic and splanchnic haemodynamics in humansC Szinnai, C Mottet, J P Gutzwiller, et al.Hepatology (Baltimore, Md.)|April 16, 1998
Hemodynamic effects of the somatostatin analog lanreotide in humans: placebo-controlled, cross-over dose-ranging Echo-Doppler studyC Mottet, C C Sieber, A Nauer, et al.Digestion|February 15, 2000
Intracellular transport of high-density lipoprotein 3 in intestinal epithelial cells (Caco-2) is tubulin associatedG Rogler, E Aschenbrenner, V Gross, et al.European Journal of Gastroenterology & Hepatology|December 14, 2001
Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's diseaseC M Gelbmann, G Rogler, M Gierend, et al.European Journal of Gastroenterology & Hepatology|November 14, 1997
Alterations of the phenotype of colonic macrophages in inflammatory bowel diseaseG Rogler, T Andus, E Aschenbrenner, et al.Pageof 62